Search Results 91-100 of 21222 for Inhibition

  1. Exploratory Study of the Impact of Lactobacillus rhamnosus GG on Proton Pump Inhibitor-Induced Gut Dysbiosis - Mayo Clinic

    Exploratory Study of the Impact of Lactobacillus rhamnosus GG on Proton Pump Inhibitor-Induced Gut Dysbiosis · Overview · Participation eligibility · Participating ...

  2. Study of Bcl-2 Inhibitor BGB-11417 in Participants With Mature B-Cell Malignancies - Mayo Clinic

    About this study. The purpose of this study is to determine the safety and tolerability of and to define the maximum tolerated dose (MTD) and Recommended ...

  3. Publications - Jessica R. Wilson, M.D. - Mayo Clinic

    ... Inhibition of Dipeptidyl Peptidase-4 by Sitagliptin". ... Dipeptidyl Peptidase 4 Inhibition Increases Postprandial Norepinephrine via Substance P (NK1 Receptor) ...

  4. AKT Inhibitor MK2206, Combined with Bendamustine Hydrochloride, and Rituximab for Treating Patients who have Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    Akt inhibitor MK2206 may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as ...

  5. Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer - Mayo Clinic

    Antihormone therapy, such as bicalutamide, may lessen the amount of androgens made by the body. Akt inhibitor MK2206 may stop the growth of tumor cells by ...

  6. Proton Pump Inhibitors Archives - Mayo Clinic News Network

    MAYO CLINIC: I regularly have heartburn and my doctor is recommending I try a proton pump inhibitor. Can you tell me more about this medication? Are there any ...

  7. A Study of Cemiplimab in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy - Mayo Clinic

    A Study of Cemiplimab in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, ...

  8. Mayo Clinic Minute: Balancing Proton Pump Inhibitor Risks and Benefits

    Patients with questions about long-term proton pump inhibitor (PPI) use are being told to consult a physician, following a study that suggests the heartburn ...

  9. Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    RATIONALE: Aurora A kinase inhibitor MLN8237 and bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. PURPOSE: ...

  10. Pharmacokinetics and Pharmacodynamic Biomarkers of Janus Kinase Inhibitor Therapy in Patients with Ulcerative Colitis (PROPHETIC Study) - Mayo Clinic

    Pharmacokinetics and Pharmacodynamic Biomarkers of Janus Kinase Inhibitor Therapy in Patients with Ulcerative Colitis (PROPHETIC Study) · Overview · Participation ...